Friday 9th February marks one year until the EU Falsified Medicines Directive (FMD) enforcement date. Although a year may sound like a long time it’s a very short period to implement a lot of changes. In this article with Pharmaceutical Manufacturing, Recipharm’s Erik Haeffler, Vice President of Manufacturing Services and Staffan Widengren, Director of Corporate Projects discuss what companies need to be thinking about as the deadline draws closer.

As a CDMO-quote

As a CDMO, we have started to encourage our customers to onboard sooner rather than later to ensure a smooth transition come the deadline.

With increasing concerns surrounding the on-boarding process and the associated timescales, Erik and Staffan talk about the importance of selecting a level 4 service provider and of companies ensuring they’re ready to start transmitting data to the European Medicines Verfication System (EMVS) and the relevant National Medicines Verification Organisations (NMVOs) come the February deadline.

Read the full article here: EU FMD: The one-year countdown

Read related articles featuring Recipharm comments here:
in-Pharma Technologist - EU serialisation: Challenges facing pharma one year out 
Manufacturing Chemist - Serialisation: one year and counting 
EPM magazine - The final countdown is on for EU FMD compliance: What are the experts saying?